Shiga toxin/verotoxin-producing Escherichia coli in humans, food and animals in the EU/EEA, with special reference to the German outbreak strain STEC O104
This joint report, produced by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA), aims to give a short summary of reported Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC) prevalence and incidence in humans, food and animals.
West Nile virus risk assessment tool
West Nile virus (WNV) is an emerging pathogen whose ecology and epidemiology extend across multiple interfaces. As the epidemiology and transmission cycle of WNV is complex, assessing the risk of WNV being transmitted to humans is not always straightforward. Therefore, the WNV risk assessment tool has been developed to provide operational guidance in support of the risk assessment process.
Avian influenza A/H5N1: Collected risk assessments, technical guidance to public health authorities and advice to the general public
The document determines the risk to human health in Europe from highly pathogenic avian influenza viruses in birds and animals and identifies areas requiring additional scientific and public health work both as single pieces of work and for risk monitoring by ECDC and its partners.
Literature review: Best practices in ranking emerging infectious disease threats
The threat of serious, cross-border infectious disease outbreaks in Europe is a significant challenge in terms of emergency preparedness. In order to effectively target the use of resources to manage the risks of outbreak, it is necessary to formulate rankings or prioritisation of human and/or animal pathogens. This literature review aims to identify the range of methods used to prioritise communicable disease threats for the purposes of emergency preparedness planning.
Response plan to control and manage the threat of multi- and extensively drug-resistant gonorrhoea in Europe
ECDC reviewed the response plan and the 2019 update strives to further support EU Member States to develop and implement national strategies and interventions to control the threat of multidrug-resistant and extensively drug-resistant gonorrhoea in a multidisciplinary approach by outlining the suggested public health response to this threat with several vital components.
Synergies in community and institutional public health emergency preparedness for tick-borne diseases in Spain
The present report is concerned with the events in Spain surrounding two cases of infection with Crimean-Congo Haemorrhagic Fever (CCHF) virus that emerged in the Autonomous Community of Castilla y León in August 2016.
Synergies in community and institutional public health emergency preparedness for tick-borne diseases in the Netherlands
The present report is concerned with the emerging infection of tick-borne encephalitis in the Netherlands — the two first endemic cases occurring in July 2016 — in the larger context of a widespread and increasing incidence of lyme borreliosis.
Interim guidance for environmental cleaning in non-healthcare facilities exposed to SARS-CoV-2
This document aims to provide guidance about the environmental cleaning in non-healthcare facilities (e.g. rooms, public offices, transports, schools, etc.) where confirmed COVID-19 cases have been before being admitted to hospital. This guidance is based on the current knowledge about SARS-CoV-2 and evidence originating from studies on other coronaviruses.
Checklist for hospitals preparing for the reception and care of coronavirus 2019 (COVID-19) patients
This document supports the public health preparedness planning for hospitals with regard to novel coronavirus disease 2019 (COVID-19).
This checklist is based on the current knowledge of the COVID-19 outbreak and the evidence available.
ECDC will update this checklist should new relevant information become available.
Guidelines for the use of non-pharmaceutical measures to delay and mitigate the impact of 2019-nCoV
This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can be adapted depending on the assessed severity/impact of the infection. Other measures are valid for all phases of an epidemic.